Mehmet Uzunel

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CLINICAL TRANSPLANTATION. 2019;33(6):e13537

The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease

Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Article: BMC PEDIATRICS. 2018;18(1):285

Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report

Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikstrom A-C; Fasth A; Ekwall O; Smith CIE
Article: PEDIATRIC TRANSPLANTATION. 2016;20(5):667-674

Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades

Svenberg P; Remberger M; Uzunel M; Mattsson J; Gustafsson B; Fjaertoft G; Sundin M; Winiarski J; Ringden O
Article: PLOS ONE. 2016;11(5):e0154737

Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Stikvoort A; Sundin M; Uzunel M; Gertow J; Sundberg B; Schaffer M; Mattsson J; Uhlin M
Article: CYTOTHERAPY. 2015;17(12):1732-1745

Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo

Sadeghi B; Heshmati Y; Khoein B; Kaipe H; Uzunel M; Walfridsson J; Ringden O
Article: CELL METABOLISM. 2015;22(3):408-417

Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis

Ryden M; Uzunel M; Hard JL; Borgstrom E; Mold JE; Arner E; Mejhert N; Andersson DP; Widlund Y; Hassan M; Jones CV; Spalding KL; Svahn B-M; Ahmadian A; Frisen J; Bernard S; Mattsson J; Arner P
Article: PEDIATRIC BLOOD & CANCER. 2015;62(5):890-896

Hypogammaglobulinemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Cytokine Mediated Immunoglobulin Isotype Class Switch Arrest?

Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
Article: IMMUNOLOGY. 2015;144(4):687-703

Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors

Bergstrom S-E; Uzunel M; Talme T; Bergdahl E; Sundqvist K-G
Article: JOURNAL OF INFLAMMATION RESEARCH. 2015;8:149-160

An ex vivo RT-qPCR-based assay for human peripheral leukocyte responsiveness to glucocorticoids in surgically induced inflammation.

Gråberg T; Strömmer L; Hedman E; Uzunel M; Ehrenborg E; Wikström A-C
Article: STEM CELLS AND DEVELOPMENT. 2014;23(14):1559-1567

T-Cell Receptor Excision Circle Levels After Allogeneic Stem Cell Transplantation Are Predictive of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2014;2014:578741-14

Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors

Radestad E; Wikell H; Engstrom M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
Article: STEM CELLS. 2013;31(3):592-601

Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Ringden O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
Article: PLOS ONE. 2013;8(9):e74534

A Research Study of the Association between Maternal Microchimerism and Systemic Lupus Erythematosus in Adults: A Comparison between Patients and Healthy Controls Based on Single-Nucleotide Polymorphism Using Quantitative Real-Time PCR

Kanold AMJ; Svenungsson E; Gunnarsson I; Gotherstrom C; Padyukov L; Papadogiannakis N; Uzunel M; Westgren M
Article: TRANSPLANTATION. 2012;94(10):1066-1074

Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation

Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: CLINICAL INFECTIOUS DISEASES. 2012;55(8):1064-1073

Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease

Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
Article: STEM CELLS. 2012;30(7):1575-1578

Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation

von Bahr L; Batsis I; Moll G; Hagg M; Szakos A; Sundberg B; Uzunel M; Ringden O; Le Blanc K
Article: STEM CELLS AND DEVELOPMENT. 2012;21(9):1409-1417

Mesenchymal Stem Cells Inhibit Thymic Reconstitution After Allogeneic Cord Blood Transplantation

Uhlin M; Sairafi D; Berglund S; Thunberg S; Gertow J; Ringden O; Uzunel M; Remberger M; Mattsson J
Article: CLINICAL IMMUNOLOGY. 2012;142(3):343-350

Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival

Sairafi D; Mattsson J; Uhlin M; Uzunel M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(6):503-509

Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders

Ringden O; Remberger M; Dahllof G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697

Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study

Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2010;162(1):146-155

Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation

Gertow J; Berglund S; Okas M; Uzunel M; Berg L; Karre K; Mattsson J; Uhlin M
Article: PEDIATRIC RESEARCH. 2010;68(3):199-204

Maternal Microchimerism in Juvenile Tonsils and Adenoids

Jonsson AM; Papadogiannakis N; Granath A; Haggstrom J; Schaffer M; Uzunel M; Westgren M
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2010;59(3):473-477

A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation

Uhlin M; Okas M; Gertow J; Uzunel M; Brismar TB; Mattsson J
Article: JOURNAL OF IMMUNOTHERAPY. 2010;33(1):96-105

Clinical Expansion of Cord Blood-derived T Cells for Use as Donor Lymphocyte Infusion After Cord Blood Transplantation

Okas M; Gertow J; Uzunel M; Karlsson H; Westgren M; Karre K; Ringden O; Mattsson J; Uhlin M
Article: BONE MARROW TRANSPLANTATION. 2009;44(11):757-763

Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism

Svenberg P; Mattsson J; Ringden O; Uzunel M
Article: JOURNAL OF IMMUNOTHERAPY. 2009;32(7):755-764

HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor

Sundin M; Barrett AJ; Ringden O; Uzunel M; Lonnies H; Dackland A-L; Christensson B; Le Blanc K
Article: LIVER TRANSPLANTATION. 2008;14(12):1793-1802

Evidence for No Relevance of Anti-Major Histocompatibility Complex Class I-Related Chain A Antibodies in Liver Transplantation

Uzunel M; Kasimu H; Joshi M; Ge X; Liu J; Xu B; Jaksch M; Jorns C; Nowak G; Sumitran-Holgersson S
Article: BONE MARROW TRANSPLANTATION. 2008;42(10):643-648

Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor

Ringden O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Article: BLOOD. 2008;112(3):532-541

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

Karlsson H; Samarasinghe S; Ball LM; Sundberg B; Lankester AC; Dazzi F; Uzunel M; Rao K; Veys P; Le Blanc K; Ringden O; Amrolia PJ
Article: BONE MARROW TRANSPLANTATION. 2008;41(11):961-964

No impact of NOD2/CARD15 on outcome after SCT

Sairafi D; Uzunel M; Remberger M; Ringden O; Mattsson J
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2008;198(3):325.e1-325.e6

Maternal microchimerism in human fetal tissues

Jonsson AM; Uzunel M; Gotherstrom C; Papadogiannakis N; Westgren M
Article: HUMAN REPRODUCTION. 2008;23(1):139-143

Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient

Mints M; Jansson M; Sadeghi B; Westgren M; Uzunel M; Hassan M; Palmblad J
Article: LEUKEMIA. 2007;21(11):2271-2276

Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon

Ringden O; Uzunel M; Sundberg B; Lonnies L; Nava S; Gustafsson J; Henningsohn L; Le Blanc K
Article: BONE MARROW TRANSPLANTATION. 2007;39(7):383-388

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases

Ringden O; Remberger M; Svenberg P; Svahn B-M; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Article: JOURNAL OF VIROLOGY. 2007;81(3):1390-1400

Inhibition of heavy chain and β₂-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replication

Guerreiro-Cacais AO; Uzunel M; Levitskaya J; Levitsky V
Article: GUT. 2007;56(2):243-252

Human liver sinusoidal endothelial cells induce apoptosis in activated T cells:: a role in tolerance induction

Karrar A; Broome U; Uzunel M; Qureshi AR; Sumitran-Holgersson S
Article: BLOOD. 2006;108(9):3112-3120

Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion

Li SS; Liu Z; Uzunel M; Sundqvist K-G
Article: TRANSPLANTATION. 2006;82(7):913-919

Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning

Uzunel M; Remberger M; Sairafi D; Hassan Z; Mattsson J; Omazic B; Barkholt L; Ringden O
Article: TRANSPLANTATION. 2006;81(10):1390-1397

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease

Ringden O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lonnies H; Marschall H-U; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Article: LIVER TRANSPLANTATION. 2005;11(8):911-921

Biliary epithelial cell antibodies induce expression of Toll-like receptors 2 and 3: A mechanism for post-liver transplantation cholangitis?

Ge XP; Uzunel M; Ericzon BG; Sumitran-Holgersson S
Article: HAEMATOLOGICA. 2005;90(8):1017-1026

Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells

Gotherstrom C; West A; Liden J; Uzunel M; Lahesmaa R; Le Blanc K
Article: CLINICAL TRANSPLANTATION. 2005;19(3):346-349

Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV

Jaksch M; Uzunel M; Remberger M; Sundberg B; Mattsson J
Article: CIRCULATION. 2004;110(24):3699-3707

Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell Populations capable of reendothelialization

Nowak G; Karrar A; Holmén C; Nava S; Uzunel M; Hultenby K; Sumitran-Holgersson S
Article: TRANSPLANTATION. 2004;78(7):1014-1020

A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation

Le Blanc K; Remberger M; Uzunel M; Mansson J; Barkholt L; Ringdén O
Article: TRANSPLANTATION. 2004;78(5):697-703

Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation

Barkholt L; Danielsson R; Calissendorff B; Svensson L; Malihi R; Remberger M; Uzunel M; Thörne A; Ringdén O
Article: LANCET. 2004;363(9419):1439-1441

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Le Blanc K; Rasmusson I; Sundberg B; Götherström C; Hassan M; Uzunel M; Ringdén O
Article: XENOTRANSPLANTATION. 2004;11(2):184-194

Adult porcine islets produce MCP-1 and recruit human monocytes in vitro

Ehrnfelt C; Kumagai-Braesch M; Uzunel M; Holgersson J
Article: BONE MARROW TRANSPLANTATION. 2004;33(1):47-52

Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation

Uzunel M; Ringdén O
Article: AMERICAN JOURNAL OF PATHOLOGY. 2003;163(4):1275-1289

Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis

Xu B; Broome U; Uzunel M; Nava S; Ge XP; Kumagai-Braesch M; Hultenby K; Christensson B; Ericzon BG; Holgersson J; Sumitran-Holgersson S
Article: BONE MARROW TRANSPLANTATION. 2003;32(5):477-483

Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation

Mattsson J; Uzunel M; Remberger M; Hassan M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2003;122(5):788-794

Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia

Uzunel M; Jaksch M; Mattsson J; Ringdén O
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2003;70(6):384-391

Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation

Remberger M; Jaksch M; Uzunel M; Mattsson J
Article: TRANSPLANTATION. 2003;75(7):1061-1066

Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans

Söderdahl G; Barkholt L; Hentschke P; Mattsson J; Uzunel M; Ericzon BG; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2003;31(3):183-190

Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation

Jaksch M; Uzunel M; Cangana GM; Remberger M; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2003;31(4):253-261

Reduced intensity conditioning regimens -: Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma

Hentschke P; Barkholt L; Uzunel M; Mattsson J; Wersäll P; Pisa P; Martola J; Albiin N; Wernerson A; Söderberg M; Remberger M; Thörne A; Ringdén O
Article: BLOOD. 2003;101(2):469-472

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

Uzunel M; Mattsson J; Brune M; Johansson JE; Aschan J; Ringdén O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;119(4):1133-1136

The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation

Nordlander A; Uzunel M; Mattsson J; Remberger M
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2002;187(2):475-482

Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency

Westgren M; Ringdén O; Bartmann P; Bui TH; Lindton B; Mattsson J; Uzunel M; Zetterquist H; Hansmann M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2001;123(1):162-169

Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation

Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;115(4):935-944

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

Mattsson J; Uzunel M; Brune M; Hentschke P; Barkholt L; Stierner U; Aschan J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2001;28(12):1161-1166

A graft-versus-colonic cancer effect of allogeneic stem cell transplantation

Zetterquist H; Hentschke P; Thörne A; Wernerson A; Mattsson J; Uzunel M; Martola J; Albiin N; Aschan J; Papadogiannakis N; Ringdén O
Article: LEUKEMIA. 2001;15(12):1976-1985

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

Mattsson J; Uzunel M; Tammik L; Aschan J; Ringdén O
Article: BLOOD. 2001;98(6):1982-1984

The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia

Uzunel M; Mattsson J; Jaksch M; Remberger M; Ringdén O
Article: TRANSPLANTATION. 2001;71(3):433-439

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

Mattsson J; Uzunel M; Remberger M; Ringdén O
Article: TRANSPLANTATION. 2000;69(10):2043-2048

Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer

Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
Article: BONE MARROW TRANSPLANTATION. 2000;25(8):843-851

Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia

Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Article: LEUKEMIA. 2000;14(2):247-254

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

Mattsson J; Uzunel M; Remberger M; Ljungman P; Kimby E; Ringdén O; Zetterquist H
Visa fler

Alla övriga publikationer

Published conference paper: BONE MARROW TRANSPLANTATION. 2018;53(1):69-77

Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients

Gaballa A; Norberg A; Stikvoort A; Mattsson J; Sundberg B; Uzunel M; Remberger M; Uhlin M
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2016;17(10):1705

T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome

Gaballa A; Sundin M; Stikvoort A; Abumaree M; Uzunel M; Sairafi D; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):47

THE IMPORTANCE OF GRAFT CELL COMPOSITION TO OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

Svenberg P; Ringden O; Uzunel M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):130-131

CLINICAL EXPANSION OF CORD BLOOD DERIVED T CELLS FOR USE AS DONOR LYMPHOCYTE INFUSION AFTER CORD BLOOD TRANSPLANTATION

Okas M; Gertow J; Uzunel M; Karlsson H; Uzunel M; Ringden O; Mattsson J; Ublin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):47

HLA MISMATCHED MSC SUPPRESS T LYMPHOCYTE ALLORESPONSES IN VITRO AND DO NOT INDUCE IMMUNOLOGICAL MEMORY IN RECIPIENTS OF MSC INFUSION

Sundin M; Barrett J; Ringden O; Uzunel M; Lonnies H; Dackland A-L; Christensson B; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):144

MINIMAL RESIDUAL DISEASE AND CHIMERISM IN CML PATIENTS RECEIVING ALLOGENEIC TRANSPLANTS AFTER MYELOABLATIVE OR REDUCED CONDITIONING

Uzunel M; Mattsson J; Hauzenberger D; Ringden O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):47

Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon

Ringden O; Uzunel M; Sundberg B; Lonnies L; Nava S; Gotherstrom C; Gustafsson J; Henningsohn L; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):40

Sensitive and quantitative chimerism analysis in AML patients with real-time PCR

Svenberg P; Uzunel M; Ringdén O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):72

No association between MIC-A polymorphism and clinical outcome after allogeneic HSCT

Uzunel M; Remberger M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):2

Mesenchymal stem cells for treatment of severe acute graft-versus-host disease

Ringden O; Uzunel M; Rasmusson I; Remberger ME; Sundberg B; Lonnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2005;11(2):42

Sensitive and quantitative chimerism analysis in all patients with real-time PCR

Uzunel M; Ulf S; Jonas M; Petter S; Marie S; Dan H; Olle R
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(2):80

Indium-III labelled donor lymphocyte infusion via hepatic artery or IV against liver metastases of renal and colon carcinoma after allogeneic haematopoietic stem cell transplantation

Barkholt L; Danielsson R; Calissendorff B; Svensson L; Malihi R; Uzunel M; Remberger M; Ringden O
Thesis / dissertation: 2003

The methodology and significance of minimal residual disease detection after allogeneic stem cell transplantation

Uzunel, Mehmet
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(1-2):1862-1864

An allogeneic anti-cancer effect after hematopoietic stem cell transplantation

Barkholt L; Hentschke P; Zetterquist H; Mattsson J; Uzunel M; Wersäll P; Martola J; Albin N; Aschan J; Wijkström H; Tillegård A; Öman S; Wernerson A; Niederwieser D; Thörne A; Ringdén O
Meeting abstract: GASTROENTEROLOGY. 2000;118(4):A1414

Tumor reduction surgery followed by allogeneic stem cell transplantation. A treatment for disseminated gastrointestinal cancer?

Thorne A; Zetterquist H; Hentchke P; Mattsson J; Uzunel M; Aschan J; Ohman S; Ringden O

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2025

Examina och utbildning

Docent, klinisk immunologi, Karolinska Institutet, 2014
MEDICINE DOKTORSEXAMEN, Institutionen för laboratoriemedicin, Karolinska Institutet, 2003

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI